PackTalk is a blog for the Healthcare Packaging Industry

MD&DI Interviews FDA Commissioner


Published on November 3, 2020

How the FDA continues to generate the science and data of a pandemic, keep the public health on active duty, and serve innovation, in the year that upended the world.

On April 1st, 2020, we published a blog post on the Herculean effort taking place between governmental and private sectors in the escalating fight against COVID-19. The collaboration aimed to, among other things, overcome stark shortages of ventilators that were anticipated across the nation.

Now it is well into fall 2020. We are a half-year older, wiser and well supplied—thanks to those early, eager partnerships forged at the front lines of the pandemic battle. Perhaps that’s why this interview with FDA commissioner, Dr. Stephen Hahn* is so rewarding to hear. Dr. Hahn took the FDA helm in December 2019—talk about hitting the ground running! Hahn speaks about what was happening then, and now, with the ongoing work of the FDA and private partners. It’s their job to oversee the entire medical industry, all while facing urgency for COVID-19 therapeutics and vaccines. It’s amazing how the FDA’s strategic goals have remained on track, vaccines are in multiple stages of research and development, and there is humble confidence to carry us forward.

READ MORE

 

SOURCES:


Comments (0)

Related Articles

One Doctor’s Request for Sustainable Change in Asia

September 17, 2021

152 kilograms. 4500 tonnes. 134 hectares. No matter how you say it, it’s not positive or sustainable. These numbers reflect the amount of medical waste from just one surgery, in a study from four hospitals over three months in New Zealand. 152 kilograms is...

Learn More

Cracking the Age Old Dilemma: Compliance or Quality?

September 17, 2021

I recently read an article from Medtech Insights on how device giants Stryker and Baxter embrace a quality first culture – and yield positive results. In the article, Stryker’s Medha Trivedi, the company’s senior director of global quality and operations said...

Learn More

Power to the PDUFA

September 17, 2021

The Prescription Drug User Fee Act was passed into law by Congress in 1992. The PDUFA implemented a fee-based framework for New Drug Applications and Biologics License Applications. One of its primary objectives was to provide funding to speed up the glacial...

Learn More

Stay Informed

To stay up to date on innovative technology and products, as well as industry trends, subscribe to Oliver’s PackTalk blog below.